Cryoport (CYRX) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

CYRX Stock Forecast

Cryoport stock forecast is as follows: an average price target of $11.50 (represents a 49.54% upside from CYRX’s last price of $7.69) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

CYRX Price Target

The average price target for Cryoport (CYRX) is $11.50 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $15.00 to $8.00. This represents a potential 49.54% upside from CYRX's last price of $7.69.

CYRX Analyst Ratings

Buy

According to 6 Wall Street analysts, Cryoport's rating consensus is 'Buy'. The analyst rating breakdown for CYRX stock is 0 'Strong Buy' (0.00%), 3 'Buy' (50.00%), 3 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Cryoport Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 07, 2024	Matthew Stanton	Jefferies	$8.00	$7.79	2.70%	4.03%
Jul 31, 2024	Yuan Zhi	B.Riley Financial	$15.00	$9.05	65.75%	95.06%
May 03, 2024	Yuan Zhi	B.Riley Financial	$19.00	$15.95	19.12%	147.07%
Apr 04, 2024	Matthew Stanton	Jefferies	$21.00	$18.34	14.50%	173.08%
Mar 13, 2024	David Saxon	Needham	$18.00	$14.36	25.35%	134.07%
May 06, 2022	Paul Knight	KeyBanc	$52.00	$24.17	115.14%	576.20%

The latest Cryoport stock forecast, released on Aug 07, 2024 by Matthew Stanton from Jefferies, set a price target of $8.00, which represents a 2.70% increase from the stock price at the time of the forecast ($7.79), and a 4.03% increase from CYRX last price ($7.69).

Cryoport Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	5
Avg Price Target	-	-	$16.20
Last Closing Price	$7.69	$7.69	$7.69
Upside/Downside	-100.00%	-100.00%	110.66%

In the current month, the average price target of Cryoport stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Cryoport's last price of $7.69. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 18, 2024	UBS	Neutral	Neutral	Hold
Aug 07, 2024	Jefferies		Hold	Downgrade
Jul 31, 2024	B. Riley	Neutral	Buy	Upgrade
May 03, 2024	UBS	Buy	Buy	Hold
May 03, 2024	B. Riley		Neutral	Downgrade
Mar 15, 2024	UBS	Buy	Buy	Hold
Jul 17, 2023	KeyBanc		Sector Weight	Downgrade
Jul 13, 2023	Needham	Buy	Buy	Hold
Feb 24, 2023	Needham	Buy	Buy	Hold
May 02, 2022	SVB Leerink	Outperform	Outperform	Hold
Feb 25, 2022	Needham	Buy	Buy	Hold
Feb 25, 2022	SVB Leerink	Outperform	Outperform	Hold

Cryoport's last stock rating was published by UBS on Oct 18, 2024. The company gave CYRX a "Neutral" rating, the same as its previous rate.

Cryoport Financial Forecast

Cryoport Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$57.26M	$56.16M	$57.02M	$62.82M	$60.36M	$60.46M	$64.15M	$52.30M	$56.44M	$56.69M	$56.19M	$53.28M	$48.36M	$11.17M	$9.39M	$9.77M	$9.24M	$9.58M
Avg Forecast	$71.26M	$69.46M	$67.24M	$66.17M	$64.30M	$62.04M	$61.33M	$58.88M	$58.64M	$58.06M	$57.56M	$58.78M	$58.39M	$55.24M	$58.29M	$62.15M	$58.26M	$69.95M	$64.58M	$52.27M	$57.71M	$54.44M	$51.15M	$46.78M	$44.03M	$10.55M	$8.93M	$9.72M	$9.20M	$9.49M
High Forecast	$73.70M	$71.84M	$69.54M	$68.44M	$66.51M	$64.16M	$63.43M	$61.37M	$59.57M	$58.13M	$57.60M	$58.85M	$60.26M	$55.24M	$60.29M	$64.28M	$60.25M	$69.95M	$64.58M	$52.27M	$57.71M	$54.44M	$51.15M	$46.78M	$44.03M	$10.55M	$8.93M	$9.72M	$9.20M	$9.49M
Low Forecast	$69.41M	$67.66M	$65.50M	$64.46M	$62.64M	$60.43M	$59.74M	$57.72M	$57.87M	$57.98M	$57.52M	$58.72M	$57.49M	$55.24M	$56.78M	$60.54M	$56.75M	$69.95M	$64.58M	$52.27M	$57.71M	$54.44M	$51.15M	$46.78M	$44.03M	$10.55M	$8.93M	$9.72M	$9.20M	$9.49M
# Analysts	4	4	4	4	3	3	3	5	6	3	3	4	7	5	6	3	2	2	2	2	3	4	5	6	9	15	9	9	16	8
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.98%	1.02%	0.98%	1.01%	1.04%	0.86%	0.99%	1.00%	0.98%	1.04%	1.10%	1.14%	1.10%	1.06%	1.05%	1.01%	1.01%	1.01%

Cryoport's average Quarter revenue forecast for Mar 24 based on 4 analysts is $58.78M, with a low forecast of $58.72M, and a high forecast of $58.85M. CYRX's average Quarter revenue forecast represents a 2.66% increase compared to the company's last Quarter revenue of $57.26M (Dec 23).

Cryoport EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	4	4	4	4	3	3	3	5	6	3	3	4	7	5	6	3	2	2	2	2	3	4	5	6	9	15	9	9	16	8
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$-12.85M	$-16.91M	$-18.33M	$-6.04M	$-9.18M	$-349.00K	$-3.79M	$-7.47M	$-4.41M	$-7.00K	$856.00K	$3.16M	$-3.18M	$-9.53M	$-4.51M	$-3.08M	$374.35K	$-11.43M
Avg Forecast	$-28.44M	$-27.72M	$-26.83M	$-26.41M	$-25.66M	$-24.76M	$-24.48M	$-23.50M	$-23.40M	$-23.17M	$-22.97M	$-4.90M	$-23.30M	$-22.05M	$-23.26M	$-4.45M	$-9.32B	$-17.84M	$-16.47M	$-4.05M	$-14.72M	$-13.88M	$-13.04M	$4.55M	$-11.23M	$-2.69M	$-2.28M	$-2.01M	$-2.35M	$-2.42M
High Forecast	$-27.70M	$-27.00M	$-26.14M	$-25.73M	$-25.00M	$-24.12M	$-23.84M	$-23.04M	$-23.09M	$-23.14M	$-22.95M	$-3.92M	$-22.94M	$-22.04M	$-22.66M	$-3.56M	$-7.46B	$-17.84M	$-16.47M	$-3.24M	$-14.72M	$-13.88M	$-13.04M	$5.46M	$-11.23M	$-2.69M	$-2.28M	$-1.61M	$-2.35M	$-2.42M
Low Forecast	$-29.41M	$-28.67M	$-27.75M	$-27.31M	$-26.54M	$-25.61M	$-25.32M	$-24.49M	$-23.77M	$-23.20M	$-22.99M	$-5.88M	$-24.05M	$-22.05M	$-24.06M	$-5.34M	$-11.19B	$-17.84M	$-16.47M	$-4.86M	$-14.72M	$-13.88M	$-13.04M	$3.64M	$-11.23M	$-2.69M	$-2.28M	$-2.42M	$-2.35M	$-2.42M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.55%	0.77%	0.79%	1.36%	0.00%	0.02%	0.23%	1.85%	0.30%	0.00%	-0.07%	0.70%	0.28%	3.54%	1.98%	1.53%	-0.16%	4.72%

4 analysts predict CYRX's average Quarter EBITDA for Sep 21 to be $-13.88M, with a high of $-13.88M and a low of $-13.88M. This is -1722.00% lower than Cryoport's previous annual EBITDA (Jun 21) of $856.00K.

Cryoport Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	4	4	4	4	3	3	3	5	6	3	3	4	7	5	6	3	2	2	2	2	3	4	5	6	9	15	9	9	16	8
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-62.39M	$-15.27M	$-20.36M	$-5.57M	$-9.44M	$-5.32M	$-9.18M	$-13.40M	$-260.09M	$-6.53M	$-5.39M	$-3.53M	$-11.53M	$-11.42M	$-5.80M	$-3.94M	$-947.54K	$-12.47M
Avg Forecast	$-11.39M	$-11.96M	$-12.40M	$-12.65M	$-12.16M	$-12.56M	$-13.21M	$-13.90M	$-14.06M	$-15.28M	$-19.60M	$-10.58M	$-14.00M	$-15.72M	$-11.72M	$-9.62M	$-9.53B	$-7.00M	$-7.43M	$-8.74M	$-7.59M	$-7.40M	$-5.98M	$-4.51M	$-1.93M	$-6.25M	$-5.26M	$-2.58M	$-3.67M	$-3.45M
High Forecast	$-11.01M	$-11.55M	$-11.98M	$-12.22M	$-11.75M	$-12.14M	$-12.76M	$-9.10M	$-9.80M	$-14.77M	$-18.94M	$-8.46M	$-11.29M	$-15.19M	$-11.32M	$-7.69M	$-7.62B	$-7.00M	$-7.43M	$-6.99M	$-7.59M	$-7.40M	$-5.98M	$-3.61M	$-1.93M	$-6.25M	$-5.26M	$-2.06M	$-3.67M	$-3.45M
Low Forecast	$-11.90M	$-12.49M	$-12.95M	$-13.21M	$-12.70M	$-13.12M	$-13.79M	$-18.69M	$-21.30M	$-15.96M	$-20.47M	$-12.69M	$-17.16M	$-16.42M	$-12.24M	$-11.54M	$-11.43B	$-7.00M	$-7.43M	$-10.49M	$-7.59M	$-7.40M	$-5.98M	$-5.41M	$-1.93M	$-6.25M	$-5.26M	$-3.09M	$-3.67M	$-3.45M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	4.46%	0.97%	1.74%	0.58%	0.00%	0.76%	1.24%	1.53%	34.28%	0.88%	0.90%	0.78%	5.99%	1.83%	1.10%	1.53%	0.26%	3.61%

Cryoport's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CYRX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Cryoport SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	4	4	4	4	3	3	3	5	6	3	3	4	7	5	6	3	2	2	2	2	3	4	5	6	9	15	9	9	16	8
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$38.81M	$36.02M	$38.80M	$33.24M	$32.63M	$30.23M	$30.56M	$26.62M	$27.59M	$23.90M	$24.69M	$21.39M	$26.25M	$14.48M	$9.03M	$7.11M	$4.74M	$15.34M
Avg Forecast	$45.87M	$44.71M	$43.28M	$42.59M	$41.39M	$39.93M	$39.47M	$37.90M	$37.74M	$37.37M	$37.05M	$21.01M	$37.59M	$35.55M	$37.52M	$19.10M	$37.50M	$43.63M	$40.28M	$17.36M	$35.99M	$33.95M	$31.90M	$27.33M	$27.46M	$6.58M	$5.57M	$4.65M	$5.74M	$5.92M
High Forecast	$47.44M	$46.24M	$44.76M	$44.05M	$42.81M	$41.30M	$40.83M	$39.50M	$38.34M	$37.42M	$37.08M	$25.21M	$38.79M	$35.55M	$38.80M	$22.92M	$38.78M	$43.63M	$40.28M	$20.83M	$35.99M	$33.95M	$31.90M	$32.79M	$27.46M	$6.58M	$5.57M	$5.57M	$5.74M	$5.92M
Low Forecast	$44.68M	$43.55M	$42.16M	$41.49M	$40.32M	$38.90M	$38.45M	$37.15M	$37.25M	$37.32M	$37.02M	$16.81M	$37.00M	$35.55M	$36.55M	$15.28M	$36.53M	$43.63M	$40.28M	$13.89M	$35.99M	$33.95M	$31.90M	$21.86M	$27.46M	$6.58M	$5.57M	$3.72M	$5.74M	$5.92M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.03%	1.01%	1.03%	1.74%	0.87%	0.69%	0.76%	1.53%	0.77%	0.70%	0.77%	0.78%	0.96%	2.20%	1.62%	1.53%	0.83%	2.59%

Cryoport's average Quarter SG&A projection for Mar 24 is $21.01M, based on 4 Wall Street analysts, with a range of $16.81M to $25.21M. The forecast indicates a -45.87% fall compared to CYRX last annual SG&A of $38.81M (Dec 23).

Cryoport EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	4	4	4	4	3	3	3	5	6	3	3	4	7	5	6	3	2	2	2	2	3	4	5	6	9	15	9	9	16	8
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-1.27	$-0.00	$-0.00	$-0.12	$-0.19	$-0.11	$-0.19	$-0.27	$-5.42	$-0.14	$-0.12	$-0.08	$-0.28	$-0.29	$-0.15	$-0.11	$-0.03	$-0.35
Avg Forecast	$-0.23	$-0.24	$-0.25	$-0.26	$-0.25	$-0.25	$-0.27	$-0.28	$-0.28	$-0.31	$-0.40	$-0.35	$-0.28	$-0.32	$-0.24	$-0.19	$-0.21	$-0.14	$-0.15	$-0.23	$-0.15	$-0.15	$-0.12	$-0.18	$-0.04	$-0.13	$-0.11	$-0.06	$-0.07	$-0.07
High Forecast	$-0.22	$-0.23	$-0.24	$-0.25	$-0.24	$-0.25	$-0.26	$-0.18	$-0.20	$-0.30	$-0.38	$-0.33	$-0.23	$-0.31	$-0.23	$-0.19	$-0.20	$-0.14	$-0.15	$-0.23	$-0.15	$-0.15	$-0.12	$-0.18	$-0.04	$-0.13	$-0.11	$-0.06	$-0.07	$-0.07
Low Forecast	$-0.24	$-0.25	$-0.26	$-0.27	$-0.26	$-0.27	$-0.28	$-0.38	$-0.43	$-0.32	$-0.41	$-0.36	$-0.35	$-0.33	$-0.25	$-0.20	$-0.21	$-0.14	$-0.15	$-0.23	$-0.15	$-0.15	$-0.12	$-0.18	$-0.04	$-0.13	$-0.11	$-0.06	$-0.07	$-0.07
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	4.48%	0.00%	0.00%	0.62%	0.93%	0.78%	1.26%	1.18%	35.25%	0.93%	0.99%	0.44%	7.17%	2.29%	1.41%	2.00%	0.35%	5.00%

According to undefined Wall Street analysts, Cryoport's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CYRX previous annual EPS of $NaN (undefined).

Cryoport Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
CDNA	CareDx	$22.14	$37.50	69.38%	Buy
CYRX	Cryoport	$8.14	$11.50	41.28%	Buy
IRTC	iRhythm	$91.45	$111.38	21.79%	Buy
BLFS	BioLife Solutions	$26.87	$30.00	11.65%	Buy
AXNX	Axonics	$70.98	$71.00	0.03%	Buy
NTRA	Natera	$168.21	$151.50	-9.93%	Buy

CYRX Forecast FAQ

Is Cryoport a good buy?

Yes, according to 6 Wall Street analysts, Cryoport (CYRX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 50.00% of CYRX's total ratings.

What is CYRX's price target?

Cryoport (CYRX) average price target is $11.5 with a range of $8 to $15, implying a 49.54% from its last price of $7.69. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Cryoport stock go up soon?

According to Wall Street analysts' prediction for CYRX stock, the company can go up by 49.54% (from the last price of $7.69 to the average price target of $11.5), up by 95.06% based on the highest stock price target, and up by 4.03% based on the lowest stock price target.

Can Cryoport stock reach $12?

CYRX's highest twelve months analyst stock price target of $15 supports the claim that Cryoport can reach $12 in the near future.

What are Cryoport's analysts' financial forecasts?

Cryoport's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $246.55M (high $255.47M, low $240.53M), average EBITDA is $-98.397M (high $-95.996M, low $-102M), average net income is $-51.824M (high $-45.755M, low $-58.305M), average SG&A $158.69M (high $164.43M, low $154.82M), and average EPS is $-1.049 (high $-0.926, low $-1.18). CYRX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $274.14M (high $283.53M, low $267.04M), average EBITDA is $-109M (high $-107M, low $-113M), average net income is $-48.401M (high $-46.771M, low $-50.557M), average SG&A $176.45M (high $182.49M, low $171.88M), and average EPS is $-0.979 (high $-0.946, low $-1.023).

Did the CYRX's actual financial results beat the analysts' financial forecasts?

Based on Cryoport's last annual report (Dec 2023), the company's revenue was $233.26M, which missed the average analysts forecast of $234.08M by -0.35%. Apple's EBITDA was $-38.101M, missing the average prediction of $-73.066M by -47.85%. The company's net income was $-99.587M, beating the average estimation of $-51.054M by 95.06%. Apple's SG&A was $146.88M, beating the average forecast of $129.76M by 13.20%. Lastly, the company's EPS was $-2.04, beating the average prediction of $-1.031 by 97.83%. In terms of the last quarterly report (Dec 2023), Cryoport's revenue was $57.26M, missing the average analysts' forecast of $58.39M by -1.94%. The company's EBITDA was $-12.853M, missing the average prediction of $-23.305M by -44.85%. Cryoport's net income was $-62.389M, beating the average estimation of $-14.002M by 345.59%. The company's SG&A was $38.81M, beating the average forecast of $37.59M by 3.27%. Lastly, the company's EPS was $-1.27, beating the average prediction of $-0.283 by 348.24%